
Certara, headquartered in Princeton, NJ, produces model-based pharmaceutical software.
How to buy shares in Certara
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – CERT – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Our top pick for
Beginners

Our top pick for
Building a portfolio

Our top pick for
Advanced traders

Certara stock price (NASDAQ: CERT)
Use our graph to track the performance of CERT stocks over time.Certara shares at a glance
Latest market close | $22.09 |
---|---|
52-week range | $16.18 - $45.48 |
50-day moving average | $19.38 |
200-day moving average | $26.42 |
Wall St. target price | $25.00 |
PE ratio | N/A |
Dividend yield | $0 (0%) |
Earnings per share (TTM) | $-0.09 |
Buy Certara shares from these brokerages
Compare special offers, low fees and a wide range of types of investments among top trading platforms.*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Certara stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Certara price performance over time
Historical closes compared with the close of $22.09 from 2022-07-01
1 week (2022-06-24) | -2.00% |
---|---|
1 month (2022-06-03) | 14.04% |
3 months (2022-04-04) | -0.63% |
6 months (2022-01-04) | -19.73% |
1 year (2021-07-02) | -18.97% |
---|---|
2 years (2020-06-30) | N/A |
3 years (2019-06-30) | N/A |
5 years (2017-06-30) | N/A |
Is Certara stock undervalued or overvalued?
Valuing Certara stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Certara's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Certara's EBITDA
Certara's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $72.8 million.
The EBITDA is a measure of a Certara's overall financial performance and is widely used to measure a its profitability.
To put Certara's EBITDA into context you can compare it against that of similar companies.
- Schrodinger (SDGR.US): USD$-113245000
- Simulations Plus (SLP.US): USD$16.3 million
- Thermo Fisher Scientific (TMO.US): USD$12.8 billion
Certara financials
Revenue TTM | $300.9 million |
---|---|
Operating margin TTM | 8.45% |
Gross profit TTM | $174.5 million |
Return on assets TTM | 1.15% |
Return on equity TTM | -1.29% |
Profit margin | -4.02% |
Book value | $6.57 |
Market capitalisation | $3.5 billion |
TTM: trailing 12 months
Certara share dividends
We're not expecting Certara to pay a dividend over the next 12 months.
You may also wish to consider:
- Simulations Plus (SLP.US) (0.48% forward annual dividend yield)
- Thermo Fisher Scientific (TMO.US) (0.22% forward annual dividend yield)
Certara overview
Certara, Inc. provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. It offers medicines to patients using biosimulation software, technology, and services to transform drug discovery and development. The company also provides related technology-enabled services to guide its customers' new drugs through the regulatory submission process and into the market. Its technology-enabled services include mechanistic biosimulation, empirical biosimulation, drug development and regulatory strategy, clinical pharmacology, model-based meta-analysis, regulatory writing and medical communications, regulatory operations, and market access. Further, company offers software, comprising mechanistic biosimulation platform, empirical PK/PD biosimulation platform, data standardization and compliance software, scientific informatics platform, clinical outcomes databases for biosimulation, authoring and management of regulatory submissions platform, and market access communication platform. The company serves biopharmaceutical companies, and academic and government institutions.
Certara in the news
Certara Introduces New Simcypâ„¢ Discovery Simulator for Early-Stage and Translational Drug Development
Certara Introduces New Simcypâ„¢ Discovery Simulator for Early-Stage and Translational Drug Development
Certara Announces New Versions of Biosimulation Software for Development of Novel Biologics
Frequently asked questions
What percentage of Certara is owned by insiders or institutions?Currently 4.283% of Certara shares are held by insiders and 87.743% by institutions. How many people work for Certara?
Latest data suggests 1,054 work at Certara. When does the fiscal year end for Certara?
Certara's fiscal year ends in December. Where is Certara based?
Certara's address is: 100 Overlook Center, Princeton, NJ, United States, 08540 What is Certara's ISIN number?
Certara's international securities identification number is: US15687V1098
More guides on Finder
-
How to buy Intchains Group (ICG) stock when it goes public
Everything we know about the Intchains Group IPO, plus information on how to buy in.
-
How to buy Biostage (BSTG) stock when it goes public
Everything we know about the Biostage IPO, plus information on how to buy in.
-
How to buy Wang & Lee Group (WLGS) stock when it goes public
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
-
How to buy OptMed (OMED) stock when it goes public
Everything we know about the OptMed IPO, plus information on how to buy in.
-
How to buy Lichen China (LICN) stock when it goes public
Everything we know about the Lichen China IPO, plus information on how to buy in.
-
How to buy LeeWay Services stock when it goes public
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
-
How to buy Nano Labs (NA) stock when it goes public
Everything we know about the Nano Labs IPO, plus information on how to buy in.
-
How to buy Warrantee (WRNT) stock when it goes public
Everything we know about the Warrantee IPO, plus information on how to buy in.
-
How to buy Treasure Global (TGL) stock when it goes public
Everything we know about the Treasure Global IPO, plus information on how to buy in.
-
How to buy BIOLIFE4D (SAVU) stock when it goes public
Everything we know about the BIOLIFE4D IPO, plus information on how to buy in.
Ask an Expert